Coloplast chief wants to unfold full potential with upcoming strategy

Four growth platforms will be the main focus when Coloplast embarks on a new strategy period in a year’s time, says the medical device company’s chief executive.
Photo: Stine Bidstrup/Ritzau Scanpix
Photo: Stine Bidstrup/Ritzau Scanpix

With about a year to go until the expiration date of Coloplast’s current strategy, CEO Kristian Villumsen is already ready to lay out the broad outlines for the company’s next strategy period, according to an interview with MedWatch in connection with the medical device company’s capital markets day held on Thursday last week. 

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading